Form 4: Health Catalyst Director, John A. Kane, Receives 20,807 Shares of Common Stock

Director John A. Kane received 20,807 shares of Health Catalyst, Inc. common stock on June 13, 2024, as part of a restricted stock unit (RSU) award.

Summary

• On June 13, 2024, John A. Kane, a director of Health Catalyst, Inc. (HCAT), acquired 20,807 shares of common stock.
• The acquisition was due to an award of Restricted Stock Units (RSUs) granted under the company's 2019 Plan.
• Each RSU represents a contingent right to receive one share of Health Catalyst's common stock.
• The RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.
• Following the transaction, Kane directly owns 130,995 shares of Health Catalyst common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral event with a slightly positive implication for investor confidence.

Positives

• The RSU grant aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency regarding the equity holdings of company insiders.

Comparison to Industry Standards

• RSU grants are a standard form of executive compensation in the technology and healthcare industries.
• Vesting schedules of one year or until the next annual meeting are also typical to incentivize continued service.
• Comparing the size of the grant to similar companies and director roles would require further analysis of Health Catalyst's compensation policies and industry benchmarks.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term performance.
• Employees may view the RSU grant as a positive sign of the company's commitment to its leadership.

Next Steps

• Monitor future Form 4 filings to track changes in insider ownership.
• Observe the vesting of the RSUs on the earlier of the one-year anniversary of the grant date or the date of the next Annual Meeting of the Issuer's Stockholders.

Key Dates